may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
�we have waited a long time and we cannot possibly wait any longer,� karmenu vella, european commissioner for environment, told the guardian.
. august 2, 2017
.
.
.
. 
august 2, 2017
.